Verastem, Inc. (VSTM) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-01-23

Key Insights

The CEO Dan Paterson has received a grant of 213,785 restricted stock units (RSUs), representing a significant equity award to align his interests with shareholders.
The RSUs vest over a 3-year period, indicating a long-term focus and commitment from the CEO to the company's success.
The insider ownership of the CEO has increased to 613,889 shares, suggesting strong alignment between management and shareholders.

Want the newest filings?

This analysis covers the filing from 2026-01-23. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-01-23

The reporting person, Daniel Calkins, was granted 16,665 restricted stock units (RSUs) as part of his compensation as the Chief Financial Officer of Verastem, Inc.
The RSUs vest over a 3-year period, with 33.3% of the RSUs vesting on each of the first three anniversaries of January 21, 2026, provided Calkins remains employed by the company.
This grant of RSUs increases Calkins' beneficial ownership of Verastem's common stock to 121,384 shares, indicating the company's commitment to incentivizing and retaining its key executive.

Filed: 2026-01-14

The Chief Financial Officer of Verastem, Inc. (VSTM) sold 5,039 shares of common stock on January 12, 2026 for $7.16 per share, reducing his total beneficial ownership to 104,719 shares.
The sale was made to satisfy statutory withholding requirements in connection with the vesting of restricted stock units, indicating a routine transaction related to executive compensation.
The transaction volume and timing do not suggest any significant changes in the CFO's confidence or the company's outlook, as the sale represents a small fraction of his total holdings.

Filed: 2026-01-14

The reporting person, Dan Paterson, who is the President and CEO of Verastem, Inc., sold 10,321 shares of the company's common stock on January 12, 2026, likely to satisfy statutory withholding requirements related to the vesting of restricted stock units.
Paterson's ownership of Verastem's common stock decreased from 410,425 shares to 400,104 shares following the reported transaction.
The sale was made pursuant to a 10b5-1 trading plan, indicating it was part of a pre-arranged strategy and not based on material, non-public information.

Filed: 2026-01-08

Michael Kauffman, the President of Development at Verastem, Inc., has been granted a stock option to purchase 200,000 shares of common stock at an exercise price of $6.88 per share, vesting over a three-year period.
The stock option grant suggests that Verastem is incentivizing its key executive to maintain a long-term focus on the company's development and growth.
Insider buying, such as this stock option grant, can signal management's confidence in the company's future prospects.

Other reports for Verastem, Inc.

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.